Pfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2002

  1. Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells

    Atherosclerosis, Vol. 160, Núm. 1, pp. 49-58

2001

  1. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.

    International Journal of Antimicrobial Agents, Vol. 18, Núm. 1, pp. 49-54